Mountain Crest Acquisition 6 (MCAH) is a blank-check SPAC incorporated in the British Virgin Islands in January 2026, with no operations, no revenue, and no identified acquisition target. MCAH is raising $60M through an IPO of 6M units at $10.00 per unit, with proceeds held in trust invested in U.S. treasuries or money market funds until a deal closes or the SPAC liquidates. The sponsor, Mountain Crest Holdings 6 LLC, received roughly 2.96M founder shares for $25,000, creating a highly asymmetric return structure — those shares would be worth ~$25.7M if a deal closes at $10.00/share. MCAH has 12 months to complete an acquisition, extendable to 18 months if the sponsor deposits additional funds per share. If no deal closes, trust proceeds are returned to public shareholders and the SPAC liquidates. MCAH is led by Dr. Suying Liu, who previously led five other Mountain Crest SPACs, completing deals with Playboy Enterprises, Better Therapeutics, ETAO International, and CH-AUTO Technology. MCAH intends to target private companies in North America and Asia Pacific with positive or near-positive operating cash flow and strong market positions, arguing it can bridge North American businesses with Asian distribution networks. The prospectus includes extensive China-specific risk disclosures, noting that MCAH may pursue a PRC-based target, which introduces risks including VIE structure complexity, PRC regulatory intervention, and potential PCAOB-related delisting risk under the HFCAA.